Will Rosellini
Tracked across 1 events · 6 articles · First seen May 08, 2026 · Last active May 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Will Rosellini, Chief IP Officer at PatentVest, commented on the new phase of obesity drug development, emphasizing the importance of intellectual property.
May 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Will Rosellini live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard